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The usefulness of current psychiatric classification, which is based on ICD/DSM categorical 
diagnoses, remains questionable. A promising alternative has been put forward as the 
“transdiagnostic” approach. This is expected to cut across existing categorical diagnoses and 
go beyond them, to improve the way we classify and treat mental disorders. This systematic 
review explores whether self-defining transdiagnostic research meets such high expectations. 
A multi-step Web of Science literature search was performed according to an a priori protocol, 
to identify all studies that used the word “transdiagnostic” in their title, up to May 5, 2018. 
Empirical variables which indexed core characteristics were extracted, complemented by a 
bibliometric and conceptual analysis. A total of 111 studies were included. Most studies were 
investigating interventions, followed by cognition and psychological processes, and 
neuroscientific topics. Their samples ranged from 15 to 91,199 (median 148) participants, with 
a mean age from 10 to more than 60 (median 33) years. There were several methodological 
inconsistencies relating to the definition of the gold standard (DSM/ICD diagnoses), of the 
outcome measures and of the transdiagnostic approach. The quality of the studies was 
generally low and only a few findings were externally replicated. The majority of studies tested 
transdiagnostic features cutting across different diagnoses, and only a few tested new 
classification systems beyond the existing diagnoses. About one fifth of the studies were not 
transdiagnostic at all, because they investigated symptoms and not disorders, a single 
disorder, or because there was no diagnostic information at all. The bibliometric analysis 
revealed that transdiagnostic research largely restricted its focus to anxiety and depressive 
disorders. The conceptual analysis showed that transdiagnostic research is grounded more 
on rediscoveries than on true innovations, and that it is affected by some conceptual biases. 
To date, transdiagnostic approaches have not delivered a credible paradigm shift that can 
impact classification and clinical care. Practical “TRANSD”iagnostic recommendations are 
proposed here to guide future research in this field.   
 
Key words: Transdiagnostic, diagnosis, classification, bibliometric analysis, conceptual 
analysis, anxiety, depression, psychosis, recommendations 
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Diagnosis, which is the medical application of the process of classification, ubiquitous in 
science, has been the cornerstone of modern clinical knowledge and practice1. Diagnosis in 
psychiatry started in Europe in the late 17th century, informed by systems that classified 
animal and plant species as part of other natural sciences2. Psychiatric nosology, traditionally 
represented by the ICD and DSM (gold standard), is based on categorical diagnoses that are 
intertwined with the key clinical dichotomies that characterize the realm of clinical medicine 
(e.g., to treat or not to treat)3,4.  
Since its inception, psychiatric nosology has always been under fire. This is documented 
by several lines of evidence, including two recent issues of this journal3,5. Although current 
diagnostic categories have demonstrated moderate to almost perfect reliability6, their 
usefulness has remained questionable7.  
A promising avenue has been put forward by the so-called transdiagnostic approach. The 
prefix “trans” comes from Latin and it can either mean across/through (e.g., transatlantic) or 
beyond (e.g., transcend)8. Therefore, a transdiagnostic approach in psychiatry is expected to 
cut across existing categorical diagnoses and go beyond them, to produce a better 
classification system, compared to the existing gold standard.  
Transdiagnostic approaches originated from cognitive behavioral theories and treatments 
for eating disorders9,10, which were then extended to anxiety11-13 and depressive disorders14. 
The initial transdiagnostic rationale leveraged two core points: a) these disorders share 
common etiological and maintenance processes9,10,13,15 as well as cognitive-affective, 
interpersonal, and behavioral features9,10,15 (e.g., the general psychopathology latent factor – 
p factor16), and b) the ever-growing number of disorder-specific treatment manuals is a barrier 
to the implementation of cognitive behavioral treatments10,13,15.  
The rationale for extending the transdiagnostic paradigm to anxiety and depressive 
disorders included an additional point that was not originally acknowledged10: c) disorder-
specific interventions rely on heterogeneous diagnostic categories and pay relatively limited 
attention to comorbidity, which is high15.  
Transdiagnostic research aims at tackling these limitations to introduce a novel approach 
that could improve the way we classify, formulate, treat, and prevent15 mental disorders. 
Moving away from a single-diagnosis approach towards a transdiagnostic conceptualization 
and treatment of mental disorders would thus be a significant paradigm shift15. Recently, 
transdiagnostic approaches have been endorsed by other paradigms that cut across different 
mental disorders, such as the Research Domain Criteria (RDoC) initiative17 and the clinical 
staging model18. At present, however, it is unclear whether transdiagnostic research meets 
such high expectations for delivering a radical paradigm shift that impacts classification and 
clinical care.  
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To address this issue, we present here a broad systematic review of transdiagnostic 
research in psychiatry. We systematically assess the transdiagnostic literature against several 
empirical variables which index core characteristics as well as potential pitfalls. A bibliometric 
and conceptual analysis complements the empirical findings, along with practical 
recommendations to guide future research in this field.   
 
 
METHODS  
 
The PRISMA compliant19 protocol for this study was registered on PROSPERO 
(CRD42018108613).  
 
Search strategy, selection criteria and data extraction 
 
A multi-step literature search was performed. First, systematic searches were conducted 
in the Web of Science (which includes Web of Science Core Collection, BIOSIS Citation Index, 
KCI - Korean Journal Database, MEDLINE, Russian Science Citation Index, and SciELO 
Citation Index), until May 5, 2018, with no restrictions on language or publication date. The 
keyword “transdiagnostic” was used, filtering for the category “psychiatry” through the Web of 
Science categories function. Second, we searched the reference lists of retrieved articles. 
Third, abstracts identified by this process were then screened and full-text articles were 
inspected against the inclusion and exclusion criteria.  
The literature search, study selection and data extraction were conducted by two authors 
(MS, NB) independently. During all stages, in the case of disagreement, consensus was 
reached through discussion with a third author (PFP).  
Studies were eligible for inclusion when the following criteria were fulfilled: a) original 
individual articles, with no restriction on study design (including interventional and 
observational studies) or topic; b) a clear and primary focus on a transdiagnostic approach, 
demonstrated by using the word “transdiagnostic” in the title.  
The exclusion criteria were: a) reviews, meta-analyses, study protocols, abstracts and 
any other non-original data; b) lacking a clear primary focus on transdiagnostic approaches, 
defined as above; and c) studies with less than ten participants20.  
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Descriptive variables  
 
For each study, we extracted descriptive variables relating to: a) general information, b) 
definition of gold standard diagnostic criteria, c) outcome measures, d) definition of the 
transdiagnostic approach, and e) quality assessment. 
General information variables included: first author and year of publication; study domain 
(classification, treatment, clinical prediction, neuroscience, cognition and psychological 
processes); study design (observational, uncontrolled interventional, controlled 
interventional); type of design (cross-sectional, longitudinal, unrandomized, randomized); total 
sample size (total pool of participants recruited at baseline, including non-clinical samples); 
and mean age (or age range). 
Variables relating to the definition of the gold standard diagnostic criteria included: 
whether the study explicitly acknowledged the type of gold standard used (DSM or ICD, any 
version); the specific type of primary diagnoses of mental disorders and their specific ICD or 
DSM codes; the presence of any other clinical condition as defined by each individual study; 
the presence of a non-clinical sample (e.g., healthy controls); the total number of ICD/DSM 
mental disorders investigated by the study; the total number of diagnostic spectra (defined 
according to the ICD diagnostic blocks: organic, including symptomatic mental disorders; 
mental and behavioral disorders due to psychoactive substance use; schizophrenia, 
schizotypal and delusional disorders; mood (affective) disorders; neurotic, stress-related and 
somatoform disorders; behavioral syndromes associated with physiological disturbances and 
physical factors; disorders of adult personality and behavior; mental retardation; disorders of 
psychological development; behavioral and emotional disorders with onset usually occurring 
in childhood and adolescence; unspecified mental disorders); and the type of psychometric 
instrument employed to define the gold standard. 
Variables relating to the outcomes included: whether the primary outcome of the study 
was clearly acknowledged in the manuscript; the specific type of instruments employed to 
define it; and the total number of primary outcomes. 
Variables relating to the transdiagnostic approach included: the exact definition of the 
transdiagnostic construct as provided by each study; the number of transdiagnostic constructs 
(single or multiple)21; whether the transdiagnostic construct was descriptive (a construct which 
is present in multiple disorders, without regard to how or why22) or mechanistic (a construct 
that may reflect an underlying physiological, neurobiological or functional mechanism22); 
whether the construct was causally associated with the outcome (to rule out the possibility 
that a construct may just be epiphenomenal21); whether the transdiagnostic construct was 
present in all clinical conditions and spectra (universal transdiagnostic process) and in how 
many of them. We also extracted the type of statistical analysis used to probe the 
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transdiagnostic construct; whether there was a formal statistical assessment of the impact of 
the transdiagnostic approach compared to the specific-diagnostic approach; and the results 
of such a test. 
Quality assessment was performed by recording if an a priori protocol had been made 
available, if funding was provided by industry, and if the core findings had been externally 
replicated in an independent sample. 
 
Analysis 
 
The descriptive variables were used to perform different types of analyses.  
First, descriptive summary data and statistics (i.e., frequencies, means/medians, ranges) 
of the above variables were narratively presented in the text and in informative tables. 
Second, each study was assessed against the criteria introduced by Mansell et al21 to 
define transdiagnostic approaches in psychiatry: a) presence of a clinical population, b) 
presence of at least four different mental disorders, c) presence of a non-clinical sample, and 
d) demonstration of the transdiagnostic construct in all mental disorders investigated.  
Third, the conceptual definition of the transdiagnostic approach was empirically 
deconstructed. The main aim was to explore the extent to which each transdiagnostic 
approach related to the existing diagnostic categorical system. As indicated in Figure 1, the 
simplest transdiagnostic approach – defined as “across-diagnoses” – was to compare different 
ICD/DSM categorical diagnoses against each other, to test their diagnostic boundaries and 
cross-cutting features. The across-diagnoses model could include one diagnostic spectrum, 
multiple spectra and/or non-clinical samples, including also healthy individuals. A more 
elaborated approach involved the definition of new diagnostic-like constructs, for example 
based on biotypes or clinical types, and then testing the relatedness of these newly defined 
constructs against the gold standard. These approaches were termed “beyond-diagnoses”, 
because they employed standard ICD/DSM diagnostic information but went beyond it, to test 
new diagnostic constructs. When studies did not fit within any of the above two categories, the 
specific approach was described.  
Fourth, we conducted a bibliometric analysis using the list of specific ICD/DSM mental 
disorders that were analyzed by each study (when available). These data were then loaded 
into R software and cleaned with the Bibliometrix and TM packages. The processed data were 
then loaded into Gephi software to generate the network map of the specific ICD/DSM mental 
disorders investigated by transdiagnostic research. Each node indicated a specific mental 
disorder, with the node’s size reflecting how many different connections (frequency) with other 
nodes were present. The thickness of the edges reflected the number of connections between 
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a pair of nodes/mental disorders. For graphical purposes, nodes that had frequency  6 and 
number of co-occurrent connections  3 were filtered out.  
 
 
RESULTS 
 
Studies identified 
 
The literature search identified 627 potential records that were screened on the basis of 
title and abstract reading. Of these, 239 were considered eligible for full screening. At this 
stage, 128 studies were further excluded, leaving a sample of 111 studies, which represented 
the final database for the current systematic review (Figure 2).   
 
Characteristics of transdiagnostic studies in psychiatry 
 
General information  
 
The first study, published in 2004 by Norton et al11, addressed the effects of a 
transdiagnostic psychological intervention for different types of anxiety disorders. Since then, 
there was one study published in 2006, six in 2008, four in 2009, six in 2012, six in 2013, 
thirteen in 2014, eleven in 2015, eighteen in 2016, thirty-four in 2017, and eleven up to May 
2018.  
Most studies (45%) were investigating interventions (of which 50% were controlled, 48% 
uncontrolled23-46, and 2% unclear47). Less than half (46%)11,43,48-68 of the interventional studies 
were randomized. All interventional studies focused on neurotic, stress-related and 
somatoform disorders or mood (affective) disorders, while other mental disorders were rarely 
investigated  (Table 1).  
Cognition and psychological processes was the second most frequent topic (28%), 
followed by neuroscientific topics (13%). Classification and prediction studies were more 
infrequent (4% and 10% respectively) (Table 1).  
The vast majority of non-interventional studies (79%) were cross-sectional, and only 
21%69-81 longitudinal. There was a large variability in study sample size, ranging from 15 
participants in the smallest study42 to 91,199 in the largest73 (median = 148 participants). The 
mean age of individuals (when available) ranged from 1044 to more than 6023 (median =  33 
years).  
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Definition of gold standard diagnostic criteria  
 
A substantial proportion (27%) of studies24,29,36,40,48,49,64,69-71,73,78,80,82-98 did not 
acknowledge using any psychometric interview to establish their gold standard diagnoses. 
Several studies (16%)29,34,54,70,71,78,82,83,85-88,92,93,95,97,99,100 did not refer to a gold standard 
diagnostic manual, but speculated on comparative benefits of the transdiagnostic approach 
over specific diagnoses29,71.  
Some studies reported non-existent (e.g., DSM-IV-TR bipolar II disorder with psychotic 
features84) or incorrect diagnoses (e.g., suicidality34, marijuana abuse/dependence76,101, late 
onset schizophrenia-like psychosis100, social anxiety disorder and social phobia as two distinct 
DSM-IV disorders101). Other studies included health anxiety within mental disorders, 
confusingly defined either as not relating to a specific diagnosis90, as hypocondriasis23, or as 
“health-based anxiety predominant in individuals with illness anxiety disorders and somatic 
symptom disorders”90.  
One interventional study stated that the participants were not diagnosed at all88. The study 
addressed this issue by simply noting that “it would have been informative to know client 
diagnoses”88, raising concerns about unnecessary or excessive treatments in this sample102.  
Some studies used comorbid (as opposed to primary) diagnoses to validate the 
transdiagnostic construct50,52,56,59-63,99,103. In about one third of studies 
(28%)34,36,54,69,70,72,74,75,82,85,87,89,104-107, the boundaries between primary and secondary 
diagnoses were not completely clear. 
There was also some confusion between the measurement of symptoms as opposed to 
categorical disorders. This was mainly due to the use of continuous measurements that were 
not translated into ICD/DSM diagnostic categories through the use of a priori cut-offs83. Three 
studies measured DSM-related items in non-clinical samples without applying cut-offs to 
establish the intake of specific diagnostic categories86,90,91. The results were there interpreted 
in the context of the disorder-oriented literature91, arguing that findings were related to specific 
categorical diagnoses86,90. These studies concurrently acknowledged a transdiagnostic 
approach in their title – as for any other study included in the current review – and “the lack of 
diagnostic measures” in the study itself91.  
An interventional study which did not use cut-offs to define post-traumatic stress disorder 
concluded that treating distress was better than treating the categorical disorder29. Another 
interventional study which measured symptoms but not disorders tautologically concluded that 
the potential advantage of transdiagnostic interventions was a reduced need for disorder-
based assessments88. Some studies did apply cut-offs but eventually did not use them for 
their main analyses48,94. 
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Frequently, studies did not specify the exact ICD/DSM types of mental disorders that were 
investigated, but only referred to the general domains of psychotic disorders34,106, substance 
induced disorders28,34,108, anxiety disorders23,28,54,88,93,104, mood disorders23,28,48,49,54,64,88,93, or 
mood and anxiety disorders54,93. The specific ICD/DSM diagnostic codes were hardly ever 
reported.  
The number of primary mental disorders investigated by each study was highly variable 
and overall relatively low, ranging from no evidence of mental disorders at all (13% of 
studies)24,29,70,78,82,85-88,90-92,95,97 and one mental disorder (8% of studies)50,59-63,96,109,110, up to 
353 mental disorders73 (median = four mental disorders per study).  Similarly, the number of 
ICD-defined diagnostic spectra was heterogeneous, ranging from zero (12% of 
studies)29,70,78,82,85-88,90-92,95,97 to ten73 (median = one spectrum) per study. The largest 
transdiagnostic study published to date leveraged an electronic case register to include 353 
mental disorders clustered across ten spectra, representing all ICD-10 mental disorders 
except organic mental disorders73. About one third of the studies (35%)29,40,70,74,76,78,81,82,85-87,90-
92,94-98,100,101,103,105-107,111-124 included at least one non-clinical sample.  
 
Outcome measures  
 
Only a minority (35%)23-25,32,34-36,40,48,49,51-53,56-62,64,66-68,73,74,83,84,88,100,103,111,112,115,125-128 of 
studies explicitly acknowledged their primary outcome measure, which may be suggestive of 
suboptimal study quality. There was also a high variability in the number of primary outcome 
measures, ranging from one48 to thirteen81 (median = two outcomes) per study.  
 
Definition of the transdiagnostic approach 
 
The exact definition of the transdiagnostic construct per study is provided in Table 1. Only 
a minority of constructs (36%) involved multiple processes28,37,38,48,55,59,70,72,75-
77,79,80,85,87,91,92,96,98,100,103,106,110,111,113,114,116,119-121,123-132. Most studies (81%) were descriptive in 
nature. Mechanistic constructs were more infrequent (19%)28,32,38,48,50-53,58,70,83,103,112-118,131,133, 
and causal transdiagnostic constructs were hardly ever reported (7%)24,48,50-53,58,115 and only 
during the most recent years (2017-2018).  
The transdiagnostic construct was demonstrated across all clinical conditions investigated 
only in a minority (34%) of studies24,27,30,32,38,42,43,45,47,50,52,53,57,58,60-63,65,71,80,83,89,96,98,109-
113,115,117,118,123,128-130,133. It was demonstrated in a median of three conditions and one spectrum. 
Several studies did not clarify at all whether the construct was present in the conditions 
investigated. Overall, no clear universal transdiagnostic construct that could be valid across 
all mental disorders and diagnostic spectra was identified.  
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The statistical methods used to test the impact of the transdiagnostic construct 
encompassed analysis of variance/covariance, correlations, regressions and general linear 
models, mixed effect models, moderation and mediation analysis, principal component 
analysis, structural equation modelling, network analysis, and machine learning. 
Less than half (44%) of the studies27,33,38,58,60,61,65,72-75,77,79-81,83,84,89,93,98,100,101,103,105,107-109,111-
121,123-133 performed a statistical comparative assessment of the transdiagnostic approach 
versus a specific-diagnostic approach. This problem was particularly relevant for interventional 
studies, half of which lacked a comparative specific-diagnostic group. Overall, only 16% of 
them27,33,38,58,60,61,65,83 performed a statistical comparative assessment. Some of these studies 
acknowledged that reliable conclusions regarding the diagnostic specificity of the findings 
could not be drawn34,64. However, other interventional studies lacking both a control group and 
statistical comparative assessment eventually (over)stated that the transdiagnostic cognitive 
behavioral treatment was effective in improving outcomes40 or that it was more effective than 
the specific-diagnostic approach29. When comparative analyses were available, they generally 
indicated similar effects of the transdiagnostic vs. the specific-diagnostic intervention58,60,61,83.  
The qualitative appraisal of the transdiagnostic vs. specific-diagnostic effects – when 
available – revealed further inconsistencies. For example, some predictive modelling studies 
indicated that the transdiagnostic approach was only able to explain an additional 1% of the 
variance109. Other studies acknowledged that the observed transdiagnostic effects were small 
in magnitude, but at the same time suggested developing transdiagnostic clinical 
interventions131.  
In general, neuroscientific studies provided better descriptions of these effects. For 
example, one of them concluded that the transdiagnostic biotypes identified specific, coherent 
associations between symptoms, behavior, brain function, and real-world function that cut 
across DSM-IV defined diagnoses111. Other neuroscientific studies demonstrated shared 
neurobiological mechanisms across current categories of mental disorders108,112,113,115,117 or 
both specific and transdiagnostic effects across mental disorders74,116,129.  
 
Quality assessment  
 
A substantial proportion of studies (40%)23,28-30,37,40,47,67,69-71,73,75,78,80,82-88,93,96-98,100,104-109,113-
118,120,124,126,128,130 did not acknowledge an a priori protocol. There were very few studies 
reporting industry involvement (4%)52,57,103,110,111. Transdiagnostic findings were hardly ever 
externally replicated, with the exception of four studies (4%)73,85,93,111. Other methodological 
weaknesses involved the use of clinical prediction methods (i.e., stepwise selection methods) 
that produce biased models109,82, in particular in small databases131,120,80. The use of small 
samples80 also led to underpowered analyses across diagnostic subgroups133.  
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Some studies interpreted overfitted and not externally replicated models to favor 
transdiagnostic over disorder-specific approaches76. Other studies conducted a large number 
of comparative analyses without controlling for multiple comparisons106. One study stated that 
participants were randomized, but eventually allocated them to a single treatment arm38. 
Another study re-analyzed data from three previously published interventional studies that 
adopted different designs, without clarifying how the final database was amalgamated47.  
 
 
Literature analysis 
 
Mansell’s transdiagnostic criteria 
 
Only three studies (3%)98,100,117 met Mansell’s transdiagnostic criteria. The most frequently 
unmet requirement was the demonstration of the transdiagnostic construct across all 
conditions investigated by the study. 
 
Type of transdiagnostic approach 
 
The majority of studies (82 out of 111, 74%) (Table 1) endorsed an across-diagnoses 
approach. Of them, 33 (40%) were conducted within the same diagnostic spectrum (three of 
which also included a non-clinical sample) and 49 (60%) were across different diagnostic 
spectra (22 of which also included a non-clinical sample) (Table 1). Only three studies 
(3%)111,126,130 endorsed a beyond-diagnostic approach. They were also the most 
methodologically sophisticated.  
For most of these across/beyond-diagnosis studies, the transdiagnostic approach was 
intertwined in the baseline recruitment of participants with different diagnoses. However, two 
studies (2%) defined their transdiagnostic approach through the inclusion of different 
diagnostic outcomes, as opposed to different patient groups at baseline (these studies were 
termed “transdiagnostic outcomes”)75,77. Two other studies (2%)24,51 defined their 
transdiagnostic approach as the overlap between physical (gastrointestinal, headache) and 
mental health (anxiety and depression) symptoms (these studies were termed “across 
physical and mental health diagnoses”).  
Despite their self-proclaimed transdiagnostic status, the remaining 22 studies (20%) were 
actually not transdiagnostic at all.  
Eight studies (7%)70,78,82,85,87,92,95,97 did not consider any ICD/DSM diagnostic information 
as gold standard nor defined any new diagnostic construct. These were usually population-
based studies which adopted a continuum rather than a categorical measurement of 
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psychopathology, the results of which were completely unrelatable to any existing ICD/DSM 
category. Therefore, these studies were termed as being “a-diagnostic” rather than 
transdiagnostic.  
Five studies (5%)29,86,88,90,91 confounded symptoms and disorders. These studies explored 
only DSM or ICD-related symptoms without any clear reference to diagnostic categories of 
mental disorders, and were therefore defined as “across symptoms”.  
Nine studies (8%)50,59-63,96,109,110 were defined as “within the same diagnosis”. Six of them 
investigated comorbid disorders in addition to a single primary disorder: comorbid depression, 
generalized anxiety disorder and social anxiety disorder in addition to panic disorder60; 
comorbid depression, generalized anxiety disorder, panic disorder in addition to social anxiety 
disorder61; comorbid generalized anxiety disorder, panic disorder or social anxiety disorder in 
addition to major depressive disorder62; comorbid major depressive disorder, social anxiety 
disorder and panic disorder in addition to generalized anxiety disorder63; comorbid panic 
disorder, social anxiety disorder, generalized anxiety disorder in addition to major 
depression50; and multiple mental disorders in addition to binge eating disorder59. Another 
study investigated comorbid depressive and anxiety symptoms (but not disorders) in patients 
with post-traumatic stress disorder110.  
Two further studies used the investigated different subtypes (restricting type and binge 
eating type) of the same disorder (DSM-IV anorexia nervosa)96 or different clinical states of 
the same disorder (never depressed, past depression, current depression)109.  
 
Bibliometric analysis 
 
Figure 3 illustrates the network of specific mental disorders that have been investigated 
by transdiagnostic research to date. A predominant focus on anxiety and depressive disorders 
is evident. 
 
 
DISCUSSION  
 
To the best of our knowledge, this is the most comprehensive review systematically 
appraising transdiagnostic research in psychiatry. The empirical analysis revealed that the 
transdiagnostic literature is heterogeneous and intrinsically incoherent. The bibliometric 
analysis showed that, to date, transdiagnostic research has focused on a limited number of 
mental disorders. The conceptual analysis leveraged these findings to demonstrate that, at 
present, transdiagnostic research does not represent a credible paradigm shift that can impact 
the classification of or clinical care for mental disorders.  
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This systematic review provides several lines of evidence showing that transdiagnostic 
approaches in psychiatry are heterogeneous. For example, only three studies out of 111 
qualified as being truly transdiagnostic, according to established criteria21. This empirical test 
demonstrates that the transdiagnostic designation is applied in a loose and unstandardized 
way, encompassing a number of different and often conflicting conceptualizations. 
Paradoxically, some of these approaches were intrinsically incoherent and incompatible 
with a transdiagnostic framework, because they investigated symptoms and not disorders 
(across-symptoms), a single disorder (within-disorder) or, to the extreme, reported no 
diagnostic information at all (a-diagnostic).  
Furthermore, transdiagnostic studies were often characterized by methodological 
weakness. For example, the exact ICD/DSM types of mental disorders were frequently poorly 
defined, raising the question of how the researchers could legitimately challenge the 
boundaries of mental disorders, if these were not even accurately determined. In addition, the 
boundaries between primary and comorbid disorders in transdiagnostic literature have often 
been blurred. Arguably, transdiagnostic approaches have been more heterogeneous, 
incoherent and paid less attention to the problem of comorbidities than the DSM/ICD 
diagnoses that were criticized for the very same problems.  
The other key methodological caveat was that transdiagnostic studies often tested several 
outcomes, enhancing the likelihood of type I error from data fishing expeditions. This problem 
was amplified by the use of arbitrary cut-offs to measure symptom severity134, a general lack 
of external replication studies, and by overenthusiastic interpretations of the results. In line 
with these arguments, there were only a few methodologically sound studies which have been 
able to identify robust mechanistic transdiagnostic constructs that were causally related with 
the outcome of interest.  
Consistent with the above limitations, most transdiagnostic studies (excluding those not 
properly transdiagnostic, as noted above) limited their analyses to the search for shared 
features across a certain set of mental disorders (across-diagnoses). However, the 
bibliometric analysis revealed that these studies remained almost entirely confined within the 
restricted original area of interest of transdiagnostic research: anxiety and depressive 
disorders.  
No universal transdiagnostic process has been identified, and the extent to which 
transdiagnostic approaches could pragmatically benefit other mental disorders and diagnostic 
spectra is undetermined. In fact, only a few transdiagnostic studies have eventually tested 
new classification systems, beyond the existing gold standard (beyond-diagnoses).  
To date, the contribution of transdiagnostic literature to the development and validation of 
an alternative classification system, which has genuine clinical value – and which is not a 
“fudge”135 – has been negligible. Notably, transdiagnostic approaches have not replaced 
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classification systems in any other branches of clinical medicine. On the contrary, continuous 
(transdiagnostic) and categorical (specific diagnostic) dimensions frequently co-exist in 
organic medicine (e.g., vascular surgery)136, as well as in psychiatry (e.g., the new DSM-5 
dimensional approach to personality disorders137). In reality, transdiagnostic studies have also 
produced evidence to support the existence of diagnostic categories130,138.  
It is thus apparent that future extensive research in this field is greatly needed, in particular 
beyond-diagnoses studies that include several diagnostic spectra. However, a key 
prerequisite would be to overcome the empirical weaknesses of current transdiagnostic 
research. To facilitate this outcome, we propose in Table 2 some pragmatic 
“TRANSD”iagnostic guidelines. We hope these guidelines will improve the consistency and 
quality of the next generation of transdiagnostic research.  
Transdiagnostic research is also affected by some significant conceptual weaknesses. 
First, it is less innovative than it often proclaims. The fundamental argument for 
transdiagnostic approaches is that diagnostic categories (mostly anxiety, depressive and 
eating disorders) are not discrete entities, because there are shared features cutting across 
them. However, twenty-four years ago, when the DSM-IV was released, an official disclaimer 
was added to its forefront: “there is no assumption that each category of mental disorder is a 
completely discrete entity with absolute boundaries dividing it from other mental disorders”139. 
It has to be considered that current polythetic (i.e., based on a list of symptoms and signs 
believed to be characteristic140) diagnostic categories originate in prototypical descriptions 
containing a core structure (gestalt) of the disorder and its polysymptomatic manifestations. 
Accordingly, the boundaries of mental disorders, as illustrated in Figure 1, are dotted, not solid. 
Unfortunately, psychiatric knowledge has overlooked these issues and, over the ensuing two 
decades, the abstract (rather than physical) nature of DSM-IV categories141 has been reified 
to the point that they are often seen as real ontological entities, discrete and demarcated from 
each other by distinct boundaries (solid lines in Figure 1). 
During this process, the symptoms shared by two or several mental disorders tended to 
be omitted from the diagnostic lists, in order to strengthen the clinical distinctiveness of the 
categories140. Therefore, transdiagnostic research represents more of a rediscovery of what 
has been forgotten from prototypical descriptions as well as the consequence of the diagnostic 
reification. In fact, it would make no sense to challenge the diagnostic boundaries without 
assuming that these do exist on some ontological level.  
Second, transdiagnostic approaches are largely based on an epistemological error, which 
triggers an illusion of continuity142. The devaluation143 and simplification of psychopathological 
phenomena – introduced by recent versions of the DSM and ICD – to brief, ordinary, non-
technical lay language descriptions, has converted complex symptoms and psychic 
phenomena into phenomenological primitives or homogeneous elementals140. For example, 
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there is only one kind of depressive state, one kind of anxiety, one kind of delusion, and it is 
assumed that all of these states share the same phenomenological structure when they are 
observed in different mental disorders140. Consequently, mental disorders, solely constituted 
by aggregates of such elementals, lose their characteristic salience, and their clinical 
boundaries become blurred140.  
An illustrative example is provided by the use of self-report psychometric scales that – not 
surprisingly – are frequently adopted in transdiagnostic research in order to reduce 
psychopathology to elementals. Some studies measured the severity of “a specific symptom 
of depression”78 in children through self-reported lay statements such as “I am sad once in a 
while”, “I am sad many times” and “I am sad all the time”78. The trivialization of the contextual 
significance of these statements144 (there are potentially infinite reasons why one could feel 
sad), is associated with the deprivation of any phenomenological framework (e.g.,  subjective 
appraisal of sadness, level of insight, presence of existential despair, perception of time)145,146. 
Such a simplification process transforms these statements into self-contained atomic 
symptoms147, which become highly blurred and aspecific, in contrast with the claim of the 
authors that they are specific symptoms. This point is empirically confirmed by the fact that 
transdiagnostic literature frequently confounded the measurement of psychometric items in 
non-clinical samples with clinical symptoms and/or established mental disorders.  
Third, the highest interest and biggest clinical contribution of transdiagnostic research has 
been in the development of emotion-focused cognitive behavioral therapy (CBT) protocols 
(e.g., the Unified Protocol58) for anxiety disorders. A recent meta-analysis indicated that these 
transdiagnostic treatments lack clinical superiority compared to diagnostic-specific treatments, 
which remain equally effective148.  
Although these results and the Unified Protocol are presented as a breakthrough, they 
are again more like a rediscovery. In fact, psychotherapy was broadly transdiagnostic, driven 
by a psychoanalytical focus on core emotional issues (termed neurotic conflicts) until 1980, 
when the DSM-III initiated a gradual splitting of psychopathology into psychiatric categories149. 
This led to an outpouring of CBT diagnosis-specific protocols, which have allowed CBT to 
balkanize and dominate the psychotherapeutic landscape for over two decades149. In this 
context, some authors have interpreted the Unified Protocol as the end of the CBT-centric 
dominion and as the resurgence of psychodynamic psychotherapies149. 
This review has some limitations. Because of the intrinsic heterogeneity in the design, 
methodology and topic covered, we were unable to perform quantitative analyses. However, 
our main aim was to provide an extensive, detailed snapshot of transdiagnostic research and 
not to produce summary estimates. Furthermore, there are most probably other studies that 
have implicitly employed transdiagnostic approaches which have not been included in this 
review. However, to deconstruct the core characteristics of transdiagnostic research, we 
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selectively focused on those studies that have explicitly acknowledged transdiagnostic 
approaches as their core distinctive features in their titles.  
In conclusion, transdiagnostic research in psychiatry has, to date, been overenthusiastic 
and undercritical, heterogeneous, intrinsically incoherent and predominantly focused on a 
limited subset of mental disorders. It is grounded more in rediscoveries than on true 
innovations, and it is demonstrably affected by conceptual biases. Medicine has always 
worked by a gradual evolutionary evidence-based process and, before rejecting time-tested 
and progressively refined concepts that are rooted in clinical tradition5,102, a reliable and valid 
alternative is needed150.  
To date, transdiagnostic approaches have not delivered the substantial empirical clinical 
“meat”135 required for them to represent a credible paradigm shift5. The risk of an acritical 
endorsement of transdiagnostic approaches would be to throw the baby out with the 
bathwater151 and be lost in a controversial102 mare magnum of diagnostic uncertainty that may 
be deleterious for patients and clinicians5.  
Transdiagnostic research has promised (too) much to psychiatry. It is hoped that this 
review will guide the next generation of transdiagnostic research to complement, refine and 
improve – less likely to replace5,136 – the way we currently classify and treat mental disorders.  
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Figure 1  Conceptual classification of transdiagnostic approaches most widely employed in psychiatry, with some prototypical diagnostic 
examples
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Figure 2  Study identification and selection (PRISMA flowchart) 
Records identified through database searching 
(N=627) 
Records screened on the 
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reading 
(N=627) 
Records excluded (N=388) 
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Full-text articles assessed 
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• not original articles 
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• article in French (N=1) 
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systematic review (N=111) 
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Table 1  Studies included in the systematic review 
 
 
Author Year Domain  Baseline 
N 
Mean 
age  
Gold 
standard  
Transdiagnostic construct  Transdiagnostic type Mansell 
criteria 
Van Dijk et al23 2018 Treatment 53 and 
64 
>60 DSM-IV-
TR 
Psychotherapeutic day treatment and 
activating day treatment 
Across diagnoses, across spectra No 
Samtani et al109 2018 Prediction 183 23 DSM-IV Repetitive negative thinking Within the same diagnosis No 
Pellizzer et al69 2018 Prediction 78 27 DSM-5 Body image flexibility Across diagnoses, within spectrum No 
Nota & Coles104 2018 Neuroscience 52 36 DSM-IV-
TR 
Repetitive negative thinking Across diagnoses, across spectra No 
McEvoy et al82 2018 Prediction 2,088 20 NA Repetitive negative thinking A-diagnostic No 
Grisanzio et al111 2018 Classification 420 40 DSM-IV Subtypes based on neurocognition, brain 
activation and functional capacity 
Beyond diagnoses No 
Goldschmidt et 
al125 
2018 Classification 636 15 DSM-5 Eating disorders symptoms network Across diagnoses, within spectrum No 
Dear et al24 2018 Treatment 28 41 DSM-IV Cognitive behavioral therapy Across physical and mental health diagnoses No 
Curzio et al129 2018 C&P processes 419 15 DSM-IV-
TR 
Binge eating, dietary restrain, affective, 
interpersonal problems and perfectionism 
Across diagnoses, within spectrum No 
Ciaramidaro et 
al105 
2018 Neuroscience 78 22 ICD-10 Facial recognition Across diagnoses, across spectra and non-
clinical samples 
No 
Capobianco et al48 2018 Treatment 40 28 DSM-IV Metacognitive and mindfulness 
meditation therapies 
Across diagnoses, across spectra No 
Zwerenz et al49 2017 Treatment 82 40 ICD-10 Psychodynamic web-based self-help 
intervention 
Across diagnoses, across spectra No 
Zemestani et al50 2017 Treatment 43 23 DSM-IV Cognitive behavioral therapy Within the same diagnosis No 
Wigman et al70 2017 C&P processes 293 19 NA Interconnectedness of psychotic and 
affective experiences 
A-diagnostic No 
Talkovsky et al25 2017 Treatment 129 33 DSM-IV-
TR 
Group cognitive behavioral therapy Across diagnoses, within spectrum No 
Talkovsky et al26 2017 Treatment 120 33 DSM-IV-
TR 
Group cognitive behavioral therapy Across diagnoses, within spectrum No 
Smith et al27 2017 Treatment 49 33 DSM-IV Anxiety symptoms questionnaire Across diagnoses, within spectrum No 
Shinn et al71 2017 Classification 91 21 NA Clinical service Across diagnoses, across spectra  No 
Sheffield et al112 2017 Neuroscience 576 35 DSM-IV Functional brain network integrity Across diagnoses, across spectra and non-
clinical samples 
No 
Sharma et al51 2017 Treatment 63 14 ICD-10 Group cognitive behavioral therapy Across physical and mental health diagnoses No 
Schroder et al52 2017 Treatment 179 37 DSM-IV Internet intervention Across diagnoses, within spectrum  No 
Riccardi et al53 2017 Treatment 28 29 DSM-IV False safety behavior elimination therapy  Across diagnoses, within spectrum No 
Platt et al72 2017 Prediction 4,925 13-18 DSM-IV Timing of menarche and internalizing 
factors 
Across diagnoses, across spectra  No 
Pitman et al28 2017 Treatment 73 29 DSM-IV Short-term psychodynamic 
psychotherapy 
Across diagnoses, across spectra No 
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Newby et al83 2017 Treatment 2,109 40 DSM-IV Internet-based cognitive behavioral 
therapy 
Across diagnoses, across spectra No 
Maia et al54 2017 Treatment 67 >18 DSM-IV, 
ICD-10 
Cognitive behavioral therapy Across diagnoses, across spectra No 
MacNamara et 
al113 
2017 Neuroscience 199 26 DSM-IV Affective face processing  Across diagnoses, across spectra and non-
clinical samples 
No 
Lee et al84 2017 Prediction 163 20 DSM-IV-
TR 
Neuropsychological functioning Across diagnoses, across spectra No 
LeBouthillier & 
Asmundson55 
2017 Treatment 48 33 DSM-5 Aerobic exercise and resistance training Across diagnoses, within spectrum No 
Keil et al114 2017 C&P processes 108 12 DSM-5 Emotions regulation Across diagnoses, across spectra and non-
clinical samples 
No 
Jauhar et al115 2017 Neuroscience 60 24 DSM-IV Dopamine synthesis capacity Across diagnoses, across spectra and non-
clinical samples 
No 
Hankin et al85 2017 C&P processes 1,125 11 NA Temperamental and psychopathology 
factors 
A-diagnostic No 
Hamblen et al29 2017 Treatment 342 57 NA Cognitive behavioral therapy  Across symptoms No 
Gros et al30 2017 Treatment 16 47 DSM-5 Cognitive behavioral therapy Across diagnoses, across spectra No 
Gong et al116 2017 Neuroscience 272 34 DSM-IV Intra/inter-network connectivity Across diagnoses, across spectra and non-
clinical samples 
No 
Gibson et al86 2017 C&P processes 2,342 21 NA Exposure to traumatic life events Across symptoms No 
Fusar-Poli et al73 2017 Prediction 91,199 33 CAARMS, 
ICD-10 
Risk model of transition to psychosis Across diagnoses, across spectra No 
Forbush et al126 2017 Classification 207 25 DSM-5 Distress and fear-avoidance internalizing 
factors  
Beyond diagnoses No 
Feldker et al117 2017 Neuroscience 134 28 DSM-IV Brain response to visual threat  Across diagnoses, within spectrum and non-
clinical samples 
Yes 
Espejo et al31 2017 Treatment 48 45 DSM-IV Group cognitive behavioral therapy Across diagnoses, within spectrum No 
Ellard et al56 2017 Treatment 29 44 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
Chen et al118 2017 Neuroscience 60 41 DSM-IV Functional connectivity density Across diagnoses, across spectra and non-
clinical samples 
No 
Chasson et al87 2017 C&P processes 3,094 15 NA Emotional vulnerabilities A-diagnostic No 
Berger et al57 2017 Treatment 139 42 DSM-IV Internet-based cognitive behavioral 
therapy 
Across diagnoses, within spectrum No 
Barlow et al58 2017 Treatment 233 31 DSM-IV, 
DSM-5 
Cognitive behavioral therapy Across diagnoses, within spectrum No 
Talkovsky & 
Norton32 
2016 Treatment 151 33 DSM-IV Group cognitive behavioral therapy Across diagnoses, within spectrum No 
Sunderland et 
al119 
2016 C&P processes 8,871 16-85 DSM-IV Two factor internalizing-substance 
dependence model 
Across diagnoses, across spectra and non-
clinical samples 
No 
Stanton et al106 2016 C&P processes 299 47 DSM-5 Emotion regulation and basic personality 
dimensions 
Across diagnoses, across spectra and non-
clinical samples 
No 
Sabharwal et al108 2016 Neuroscience 82 45 DSM-IV Behavioral and neural measures of 
emotion-related working memory 
Across diagnoses, across spectra No 
Reininghaus et 
al130 
2016 Classification 1,168 42 RDoC Bifactor model with general and specific 
psychosis dimensions 
Beyond diagnoses No 
 30 
Philip et al74 2016 Prediction/neuro
science 
46 39 DSM-IV-
TR 
Thalamic connectivity in early life stress Across diagnoses, across spectra and non-
clinical samples 
No 
Morris et al88 2016 Treatment 108 41 NA Group based psychological intervention Across symptoms No 
McIntosh et al59 2016 Treatment 112 35 DSM-IV Cognitive behavioral therapy Within the same diagnosis No 
McEvoy & Erceg-
Hurn33 
2016 Treatment 256 34 DSM-IV Intolerance of uncertainty Across diagnoses, across spectra No 
Kristjánsdóttir et al 
34 
2015 Treatment 287 39 DSM-IV, 
ICD-10 
Group cognitive behavioral therapy  Across diagnoses, across spectra No 
Ito et al35 2016 Treatment 28 35 DSM-IV Cognitive behavioral therapy Across diagnoses, across spectra No 
Holliday et al89 2016 C&P processes 783 29 DSM-5 Distress tolerance  Across diagnoses, across spectra No 
Hadjistavropoulos 
et al36 
2016 Treatment 458 39 DSM-IV Internet-based cognitive behavioral 
therapy 
Across diagnoses, across spectra  No 
Fogliati et al60 2016 Treatment 145 41 DSM-IV Cognitive behavioral therapy Within the same diagnosis No 
Dear et al61 2016 Treatment 233 42 DSM-IV Cognitive behavioral therapy Within the same diagnosis No 
Conway et al75 2016 C&P processes 815 15 DSM-IV Internalizing and externalizing factors 
mediating appraisal biases 
Transdiagnostic outcome No 
Conway et al107 2016 Prediction 700 20 DSM-IV Latent model of personality disorder Across diagnoses, across spectra and non-
clinical samples 
No 
Asnaani et al37 2016 Treatment 107 33 DSM-5 Anxiety sensitivity, depression, 
rumination as moderators of cognitive 
behavioral therapy 
Across diagnoses, within spectrum No 
Titov et al62 2015 Treatment 290 44 DSM-IV Cognitive behavioral therapy Within the same diagnosis No 
Thibodeau et al90 2015 C&P processes 1,255 22 DSM-IV-
TR 
Intolerance of uncertainty Across symptoms No 
Tang-Smith et al91 2015 C&P processes 612 21 DSM-III Dominance behavioral system Across symptoms No 
Rodriguez-Seijas 
et al127 
2015 C&P processes 5,191 NA DSM-IV Internalizing and externalizing factors Across diagnoses, across spectra No 
Pietrzak et al110 2015 C&P processes 267 54 DSM-IV Loss symptoms, threat symptoms and 
somatic symptoms 
Within the same diagnosis No 
Maia et al99 2015 Treatment 48 18-58 DSM-IV, 
ICD-10 
Cognitive behavioral therapy Across diagnoses, across spectra No 
Latack et al76 2015 C&P processes 34,653 >18 DSM-IV Internalizing and externalizing factors Across diagnoses, across spectra and non-
clinical samples 
No 
Hsu et al131 2015 C&P processes 51 33 DSM-IV Self-reported attentional control and 
rumination 
Across diagnoses, across spectra No 
Dear et al63 2015 Treatment 366 44 DSM-IV Cognitive behavioral therapy Within the same diagnosis No 
Corral-Frías et 
al101 
2015 Neuroscience 906 20 DSM-IV Ventral striatal reactivity to reward   Across diagnoses, across spectra and non-
clinical samples 
No 
Bedwell et al120 2015 Neuroscience 48 36 DSM-IV Visual evoked potentials Across diagnoses, across spectra and non-
clinical samples 
No 
Vann et al128 2014 C&P processes 27 26 DSM-IV-
TR 
Metacognitions Across diagnoses, within spectrum No 
Talkovsky & 
Norton38 
2014 Treatment 256 33 DSM-IV Negative affectivity, anxiety sensitivity, 
intolerance uncertainty 
Across diagnoses, within spectrum No 
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Starr et al77 2014 Prediction 1,630 28 DSM-IV Latent internalizing factors for 
psychopathology 
Transdiagnostic outcome No 
Spielberg et al121 2014 Neuroscience 179 27 DSM-IV Dimensions of anxiety and depression Across diagnoses, across spectra and non-
clinical samples 
No 
Queen et al39 2014 Treatment 59 15 DSM-IV Cognitive behavioral therapy Across diagnoses, across spectra No 
Pietrzak et al103 2014 Neuroscience 35 29 DSM-IV-
TR 
Threat and loss symptoms Across diagnoses, across spectra and non-
clinical samples 
No 
Newby et al40 2014 Treatment 707 40 DSM-IV Internet-based cognitive behavioral 
therapy 
Across diagnoses, across spectra and non-
clinical samples 
No 
McLaughlin et al78 2014 Prediction 1,065 12 NA Rumination A-diagnostic No 
McEvoy et al122 2014 C&P processes 786 28 DSM-IV Repetitive negative thinking Across diagnoses, across spectra and non-
clinical samples 
No 
Gros41 2014 Treatment 29 50 DSM-IV Cognitive behavioral therapy Across diagnoses, across spectra No 
Cameron et al92 2014 C&P processes 41 28 NA Emotion perception and semantic 
memory 
A-diagnostic No 
Bullis et al42 2014 Treatment 15 32 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
Bohnke et al93 2014 C&P processes 11,939 38 DSM-IV Negative affectivity Across diagnoses, across spectra No 
Norton et al47 2013 Treatment 79 33 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
McEvoy et al132 2013 C&P processes 513 37 DSM-IV Repetitive negative thinking Across diagnoses, across spectra No 
McEvoy & 
Mahoney133 
2013 C&P processes 99 NA DSM-IV Intolerance of uncertainty and negative 
metacognitive beliefs 
Across diagnoses, within spectrum No 
Johnson et al94 2013 C&P processes 334 19 DSM-IV Impulsive responses to emotion Across diagnoses, across spectra and non-
clinical samples 
No 
Ebert et al64 2013 Treatment 400 45 ICD-10 Internet-based maintenance treatment Across diagnoses, across spectra No 
Boswell et al43 2013 Treatment 54 30 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
Norton & 
Barrera65 
2012 Treatment 46 31 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
Norton66 2012 Treatment 87 33 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
Hoiles et al95 2012 C&P processes 224 31 NA Cognitive model for eating disorder A-diagnostic No 
Farchione et al67 2012 Treatment 37 29 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
Conway et al79 2012 C&P processes 815 15 DSM-IV Internalizing and externalizing factors Across diagnoses, across spectra  No 
Bilek & 
Ehrenreich-May44 
2012 Treatment 22 10 DSM-IV Group cognitive behavioral therapy Across diagnoses, within spectrum No 
Innis et al96 2009 Neuroscience 135 28 DSM-IV Homocysteine remethylation Within the same diagnosis No 
Hagenaars et al123 2009 C&P processes 252 29 DSM-IV Trauma and panic memories Across diagnoses, within spectrum and non-
clinical samples 
No 
Fairburn et al68 2009 Treatment 154 26 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
Bentall et al100 2009 C&P processes 237 53 DSM-IV, 
ICD-10 
Paranoia, cognitive performance and 
depressive style 
Across diagnoses, across spectra and non-
clinical samples 
Yes 
Norton et al46 2008 Treatment 54 32 DSM-IV Group cognitive behavioral therapy Across diagnoses, within spectrum No 
Norton45 2008 Treatment 52 33 DSM-IV Group cognitive behavioral therapy Across diagnoses, within spectrum No 
McFarlane et al80 2008 Prediction 58 30 DSM-IV Predictors of relapse Across diagnoses, within spectrum No 
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Corcoran et al124 2008 C&P processes 148 38 DSM-IV Theory of mind and jumping to 
conclusions 
Across diagnoses, across spectra and non-
clinical samples 
No 
Brown et al97 2008 C&P processes 38 20 NA Measure of mundane meaning A-diagnostic No 
Bentall et al98 2008 C&P processes 148 38 DSM-IV Negative self-esteem and negative 
expectations 
Across diagnoses, across spectra and non-
clinical samples 
Yes 
Wade et al81 2006 C&P processes 1,002 35 DSM-IV Dimensional model of eating disorders Across diagnoses, across spectra and non-
clinical samples 
No 
Norton et al11 2004 treatment 23 >19 DSM-IV Cognitive behavioral therapy Across diagnoses, within spectrum No 
 
 
C&P processes – cognition and psychological processes, CAARMS – Comprehensive Assessment of At Risk Mental State, RDoC – Research Domain Criteria, NA – not available 
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Figure 3  Network map of specific mental disorders analyzed by transdiagnostic research in psychiatry to date. Each node indicates a specific 
mental disorder, with the node’s size reflecting how many different connections with other nodes were present. The thickness of the edges 
reflects the number of connections between a pair of nodes/mental disorders.
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Table 2  “TRANSD”iagnostic research recommendations in psychiatry 
 
Transparent definition of the gold standard (ICD, DSM, other), including 
specific diagnostic types, official codes, primary vs. secondary diagnoses, 
diagnostic assessment interviews. 
 
Report the primary outcome of the study, the study design and the 
definition of the transdiagnostic construct in the abstract and main text. 
 
Appraise the conceptual framework/approach of the transdiagnostic 
approach: across-diagnoses, beyond-diagnoses, other (explain). 
 
Numerate the diagnostic categories, spectra and non-clinical samples in 
which the transdiagnostic construct is being tested and then validated.  
 
Show the degree of improvement of the transdiagnostic approach against 
the specific diagnostic approach through specific comparative analyses. 
 
Demonstrate the generalizability of the transdiagnostic construct through 
external validation studies. 
 
 
